“Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β/Smad Signaling” (2026) The Review of Diabetic Studies, pp. 62–76. doi:10.70082/y1zx3j95.